Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -5652.38% is 8479% below its 3-year average of -65.88%, near the low end of its 3-year range (-5652.38%–0.00%).
306.07% below its 12-month average of -1391.96%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -658.85%.
OPERATING MARGIN
-5652.38%
OPERATING MARGIN AVG TTM
-1391.96%
OPERATING MARGIN AVG 3Y
-65.88%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-306.07%
CURRENT VS 3Y AVG
-8479.18%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 386 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Bullfrog AI Holdings, Inc. Common Stock
Market Cap
$11.01M
Operating Margin
-5652.38%
TTM Avg
-1391.96%
3Y Avg
-65.88%
5Y Avg
0.00%
Market Cap
$10.74M
Operating Margin
-293.46%
TTM Avg
-272.89%
3Y Avg
-2404.23%
5Y Avg
-2129.99%
Market Cap
$11.41M
Operating Margin
-21.94%
TTM Avg
-34.04%
3Y Avg
-49.86%
5Y Avg
-59.16%
Market Cap
$11.42M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.27M
Operating Margin
-140807.24%
TTM Avg
-140807.24%
3Y Avg
-140807.24%
5Y Avg
-140807.24%
Market Cap
$11.95M
Operating Margin
N/A
TTM Avg
-2960.13%
3Y Avg
-1713.73%
5Y Avg
-1142.49%
Market Cap
$9.79M
Operating Margin
-11268.32%
TTM Avg
-39020.24%
3Y Avg
-22313.14%
5Y Avg
-16433.29%
Market Cap
$12.46M
Operating Margin
-33.37%
TTM Avg
-42.32%
3Y Avg
-69.57%
5Y Avg
-60.22%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $11.01M | -5652.38% | -1391.96% | -65.88% | 0.00% |
| BioVie Inc. (BIVI)vs › | $10.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cerenome, Inc. (CNSY)vs › | $10.74M | -293.46% | -272.89% | -2404.23% | -2129.99% |
| Biofrontera Inc. (BFRI)vs › | $11.41M | -21.94% | -34.04% | -49.86% | -59.16% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.42M | 0.00% | 0.00% | 0.00% | 0.00% |
| Caring Brands, Inc. (CABR)vs › | $10.27M | -140807.24% | -140807.24% | -140807.24% | -140807.24% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.95M | N/A | -2960.13% | -1713.73% | -1142.49% |
| Ainos, Inc. (AIMD)vs › | $9.79M | -11268.32% | -39020.24% | -22313.14% | -16433.29% |
| Cytosorbents Corporation (CTSO)vs › | $12.46M | -33.37% | -42.32% | -69.57% | -60.22% |
| Dare Bioscience, Inc. (DARE)vs › | $12.63M | -1315.51% | -120503.86% | -60605.86% | -40403.91% |
Gross Margin
18.8%
Operating Margin
-5652.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -658.85% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | -1881.82% |
| 2025-06-30 | -4419.14% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | -2006.38% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -5830.43% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
